RxPG News Feed for RxPG News

Medical Research Health Special Topics World
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
 Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Physiotherapy
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate

Last Updated: Feb 19, 2013 - 1:22:36 AM
Research Article
Latest Research Channel

subscribe to Latest Research newsletter
Latest Research

   EMAIL   |   PRINT
New research reveals challenges in genetically engineered crop regulatory process

May 8, 2012 - 4:00:00 AM
If APHIS can solicit public comment earlier in the regulatory process, it can more efficiently incorporate stakeholder concerns into either the environmental assessment or the environmental impact statement that it prepares in conjunction with its regulatory decision, says McGinnis.

 
[RxPG] May 7, 2012 - A new innovation can completely reshape an industry-- inspiring both optimism and debate. The development of genetically engineered (GE) crops in the 1980's ignited a buzz in the agricultural community with the potential for higher crop yields and better nutritional content, along with the reduction of herbicide and pesticide use. GE crops grew to play a significant role in the U.S., with more than 160 million acres of farmland used to produce GE crops in 2011. However, the development of new GE crops has recently slowed to a trickle due to litigation over field testing and deregulation. University of Minnesota researchers Esther McGinnis, Alan Smith, and Mary Meyer set out to determine the cause of these litigation lulls responsible for slowing GE progress in the U.S.

Three federal agencies are responsible for regulating plant biotechnology in the United States. The Food and Drug Administration (FDA) oversees food and animal feed safety aspects of GE crops. The Environmental Protection Agency (EPA) is responsible for crops engineered to produce pesticidal substances. Lastly, the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) regulates the planting of GE crops under the Plant Protection Act, introduced in 2000, to consolidate related responsibilities previously spread across various legislative statutes.

APHIS regulates GE crops if the donor organism, recipient organism, or vector or vector agent meets the plant pest definition or the APHIS administrator believes the organism to be a plant pest. The agency's regulatory decisions have met much criticism in the last decade, inspiring the U of M research team to determine if and where APHIS may have gone wrong. The team used past lawsuits as case studies to determine whether APHIS failed to recognize the environmental impacts of GE crops and made legal errors in failing to comply with the sometimes strict procedures of U.S. environmental law.

After rising exponentially in the mid-1980s, the first commercially grown GE crop, the Flavr Savr tomato, was approved for sale in the U.S. in 1994. Many farmers since then, adopted GE crops as their own, excited by the prospects of scientific advancement and financial reward.

GE crop testing declined rapidly in 2003 in response to the first lawsuit. Before that time, APHIS was dealing with a pretty heavy case load, says McGinnis. Their compliance with NEPA may have slipped and left them vulnerable to lawsuits.

NEPA, the National Environmental Policy Act, is a U.S. national policy that was established in 1969 to promote environmental protection. NEPA requires environmental agencies to keep an in-depth administrative record of their actions that validates the agency's rationale in reaching regulatory decisions. The lack of transparency in creating these administrative records has been a point of criticism APHIS has faced in recent years.

McGinnis and her fellow researchers also pointed out that many of the lawsuits used in their study demonstrate that APHIS failed to differentiate between traditional GE crops, such as corn, soybeans, and cotton, and new GE crops presenting considerable regulatory challenges.

Take the genetic engineering of creeping bentgrass, for example. This weedy, wind-pollinated perennial raises unique gene flow concerns that aren't seen in more traditional herbicide-tolerant crops. APHIS has failed to distinguish novel GE crops like this one and hold them to the rigorous evaluation standards required by environmental law, which has led to lawsuits that have grounded the GE crop regulatory process to a halt.

APHIS needs to prioritize its resources. It needs to be spending more time regulating novel crops, says McGinnis. I'm certainly not advocating more regulation of traditional agronomic crops. Really, it's about focusing on these novel crops that raise more issues.

APHIS has recently announced plans to streamline their regulatory review process of GE crops, and plans on implementing several efficiency improvements. These include executing more defined deadlines, better resource management, and earlier opportunity for public involvement.

If APHIS can solicit public comment earlier in the regulatory process, it can more efficiently incorporate stakeholder concerns into either the environmental assessment or the environmental impact statement that it prepares in conjunction with its regulatory decision, says McGinnis.

While APHIS says it has already begun to apply new, more efficient process steps and more defined deadlines, changes to public engagement have yet to be implemented. The agency's complete set of revised procedures go into effect after the plans are published in the Federal Register.



Related Latest Research News
Study identifies a genetic risk factor for persistent pain
New research helps place modern temperatures into a more complete statistical framework
Most effective PTSD therapies are not being widely used, researchers find
Center for Pharmaceutical Advancement and Training Inauguration Event
American College of Physicians unveils tools to improve acute coronary syndrome care
Reactivating memories during sleep
Secrets of bacterial slime revealed
Johns Hopkins experts to present genetics advances at international meeting this weekend
Cheers to better beer and disease resistance
Disappearing nannies force parents to accept their duties

Subscribe to Latest Research Newsletter

Enter your email address:


 Feedback
For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 
Contact us

RxPG Online

Nerve

 

    Full Text RSS

© All rights reserved by RxPG Medical Solutions Private Limited (India)